A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?

PURPOSE: Pharmacogenomics (PGx) studies how inherited genetic variations in individuals affect drug absorption, distribution, and metabolism. PGx panel testing can potentially help improve efficiency and accuracy in individualizing therapy. This study compared the cost-effectiveness between preempti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ye, Moriarty, James P., Swanson, Kristi M., Takahashi, Paul Y., Bielinski, Suzette J., Weinshilboum, Richard, Wang, Liewei, Borah, Bijan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935716/
https://www.ncbi.nlm.nih.gov/pubmed/33041335
http://dx.doi.org/10.1038/s41436-020-00995-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935716/
https://www.ncbi.nlm.nih.gov/pubmed/33041335
http://dx.doi.org/10.1038/s41436-020-00995-w

Ejemplares similares